How is India leading the pharma industry with the Top pharma exporters in India?

1
(No Transcript)
2
How is India leading the pharma industry with the
Top pharma exporters in India?

• The Indian pharmaceutical industry has come a
  long way from being an import-dependent to
  becoming a self-sufficient manufacturer and one
  of the worlds major exporters. Today, the Indian
  pharmaceutical business is the worlds
  third-biggest by volume, with a market value of
  more than 42 billion.
• Top pharma exporters in India export medicines to
  around 206 countries, with the United States
  being the most important export destination,
  followed by Africa and Europe. It is a vaccine
  production leader, supplying more than 60 of
  worldwide vaccination demand. The Indian
  pharmaceutical industrys goods continue to
  enhance health outcomes for patients globally,
  with an export value of 24.44 billion (2020-21).
  This has been made feasible by the Government of
  Indias policy initiatives and the
  entrepreneurialism of Indian business.

3
How is India leading the pharma industry with the
Top pharma exporters in India?

• The Government of India recognized the
  pharmaceutical business as a rising sector of the
  economy in the recent Union Budget 2022, which is
  predicted to triple in the next decade. The
  pharmaceutical business is expected to reach 65
  billion by 2024, according to the Indian Economic
  Survey 2021-2022. By 2030, the sector hopes to be
  worth 120-130 billion. In order to do this, the
  industry may begin on a strategy of developing
  Indias worldwide leadership in life sciences
  while promoting greater local access and
  affordability.
• Lets see how India is leading the pharma
  industry.

4
Top Pharma Exporter in India Leading the Pharma
industry

• The best Indian pharma companies, such as JoinHub
  Pharma, have made a global impression by their
  price competitiveness and high quality, which has
  resulted in India producing 60 of the worlds
  vaccines and 20 of generic medications. Another
  interesting statistic is that around 55 percent
  of Indias pharmaceutical exports are too highly
  regulated. Indian pharmaceutical exporters also
  have a significant presence in the prescription
  market in the United States and the European
  Union.
• Even after global trade interruptions and a
  reduction in demand for COVID-19-related
  medications, the growth of pharmaceutical exports
  has increased. The trade balance goes in Indias
  favor, with a USD 15175.81 million surpluses.
  India is ranked third in terms of output and
  fourteenth in terms of value. The Indian
  pharmaceutical industry is currently worth
  roughly USD 50 billion

5
Top Pharma Exporter in India Leading the Pharma
industry

• Formulations and biologicals account for around
  73.31 percent of our overall exports, followed by
  bulk medicines and drug intermediates, which
  account for USD 4437.64 million. The top 5 pharma
  export destinations for India are the United
  Kingdom, South Africa, Nigeria, Russia, and the
  United States.
• Despite the COVID crisis, the Indian
  pharmaceuticals and drugs business had a rapid
  expansion, with exports reaching USD 24.4
  billion, increasing 18 percent year on year. The
  astonishing export growth accomplishment in
  2020-21 was accomplished despite regular
  lockouts, global supply chain disruptions, and a
  weak manufacturing sector. As part of the trade
  accords, India signed a cooperation deal with the
  UAE and Australia, which will provide Indian
  pharmaceutical products with greater access to
  these markets.

6

• Export to America

• North America continues to be the biggest market
  for Indian medicines, accounting for more than
  34 of total sales. Exports to the USA, Canada,
  and Mexico increased by 12.6 percent, 30 percent,
  and 21.4 percent.

• African exports

• Exports to Africa grew 13.4 percent, compared to
  2.24 percent growth in the previous fiscal year.
  South Africa has emerged as Indias
  second-largest market for medicines. Exports to
  the country climbed by 28, with Nigeria, Kenya,
  and Tanzania serving as the other key African
  markets.

7
Leading the Post-Pandemic World

• After making major contributions to generics, the
  pharmaceutical industry is now set to enhance its
  innovation and research and development (RD)
  abilities in order to deliver cutting-edge
  medicines at competitive rates. Its time to
  transition from Make in India to Discover and
  Make in India. The emphasis would be on boosting
  RD and innovation, smart manufacturing,
  fostering policy changes, driving digital
  transformation, and cultivating useful
  collaborations.

• Foster policy reforms

• A robust and efficient regulatory environment,
  such as having a single window system,
  eliminating several regulatory organizations, and
  developing precise rules, is critical for a
  healthy innovation environment. Following the
  pandemic, it is necessary to continue a
  conversation between the regulator and the
  industry, for example, through pre-approval
  discussions, regular industry meetings, and
  rolling reviews.

8

• Focus on RD and innovation

• The Indian pharmaceutical industry, which
  accounts for two-thirds of the world
  pharmaceutical market, would need to move up the
  value chain and focus on innovation. By 2047, the
  Indian pharmaceutical industry must develop a
  robust innovation pipeline (5-7 novel molecular
  entities and 1012 innovation releases per year).
• To that end, the business is increasingly
  branching out into sophisticated generics and
  specialized pharmaceuticals. The goal is to
  increase Indian pharmas significance in
  biologics, new drug development, and innovation
  and improve skills in biological sciences,
  information technology utilization, cell and gene
  therapy, and other areas focused on patient
  requirements.

9

• Digital transformation

• Enhanced patient care, cost-effectiveness, better
  transparency, improved production, and drug
  research all require digital transformation.
  AR/VR, artificial intelligence (AI), machine
  learning (ML), 3D printing, and additive
  manufacturing are supporting pharma businesses in
  speeding up the research and development process,
  running testing in less time, adding newness to
  goods, and enhancing production efficiency and
  compliance. Because of the growing usage of
  digital technologies, telemedicine, and app-based
  ecosystems, supply chains are also becoming more
  patient-centric.

• Nurture valuable collaborations

• During the COVID 19 outbreak, the government,
  academia, and pharma businesses supported
  research efforts. The regular feedback,
  integrated efforts, sharing, and persistent
  discussion between industry stakeholders and
  government authorities worked successfully, and
  this engagement should continue in the future.

10

• Focus on exports

• In the future, it will be vital for the industry
  to consolidate existing significant export
  markets while also exploring new ones. In this
  scenario, Indian embassies overseas might be
  excellent facilitators. At the same time,
  policies in India would need to focus on
  assisting the industry in becoming more
  competitive in the export market through policy
  instruments such as RoDTEP and PLIs and
  incentivizing RD and innovation in the pharma
  sector.

11
The Road Ahead

• India has a technological edge and world-class
  industrial capabilities that have been developed
  through time. This capability is crucial in
  regulated and science-driven industries, where
  the rate of change is likely to accelerate over
  the next two decades. The ability to adjust
  quickly will be critical to remaining
  competitive.
• Indian business has proved its dedication to
  patient welfare, particularly during the
  epidemic, and will do so in the future.
  Nonetheless, the key to supplying excellent
  medications at cheap rates will be to be a
  technological leader and exploit Indias
  demographic advantage to become a life sciences
  hub.

12
The Road Ahead

• Looking for a reliable pharma exporter in India?
  Partner with JoinHub Pharma. We are the trusted
  pharma exporter, supplier, and wholesaler from
  India. We manufacture and sell high-quality
  branded and generic medicines at affordable rates
  and improve peoples health across the world.
• Want to know more about pharmaceutical exports or
  pharma product manufacturing? Simply drop us a
  line at info_at_joinhubpharma.com.
• Our pharma exports will get in touch with you
  within 24 hours.

13
Contact Us Today For All Your Requirement Related
To Pharmaceutical Products